chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I had my First dose 2/1/21 and second dose administered 3/5/21. I initially started getting headaches and pressure in my right ear. I thought I had an ear infection for a month and a half but did not. Starting the end May I stated having vision changes in my Right eye. My eye was very sensitive to light, blurry when changing rooms or from inside to outside to sunlight. By the beginning of July I lost all vision in my Right eye. I was seen my an Ophthalmologist and He referred me to a Neuro-Ophthalmologist. I saw him on Aug 6th and I had severe swelling and build up of fluid behind my right eye and some starting to build up behind my Left eye. He sent me to ER to have a MRI to rule out a brain tumor. My MRI (8/6/21)showed no masses. They did a lumbar puncture to relieve fluid on my spine,  My pressure reading was a 36. They put me on a diuretic and sent me home and that they would call me when results from the spinal fluid tests. All testing came back normal with no infections or diseases. (8/15/21) I ended up a week later very nauseous and vomiting for 48 hours straight. I went back to the ER and they did a 2nd spinal tap. My pressure reading this time was a 44. They drained more fluid and sent me home with an appointment with a neurologist.  She increased my diuretic meds to 1,000 mg 2x day. She got me an appoint to see a Neuro-Ophthalmologist. I had another MRI done (9/8/21)before I saw him on (9/9/21). The Neuro Ophthalmologist was very concered with my vision loss, headaches and said i had extreme fluid and pressure build up. He was concerned my optic nerve had so much swelling that it may be severed.   He got me in to see a NeuroSurgeon the next day on (9/10/21). He sent me directly to Hospital to be admitted. I had a CT done of my spine to rule out fatty deposits on my spine. That CT came back clear. I was admitted and had an Angiogram and Venogram on (9/11/21). I had brain surgery on 9/12/21 and was told i had a 2nd blockage that would need surgery in 6 months and would monitor until then. If that blockage worsens i would have it done on an emergency basis before 6 months
Moderna Covid arm rash appeared 7-1/2 days after vaccine administration.  Mildly itchy,  red rash approximately 4? x 2? in size.   The rash lasted approximately 48 hours.
1 minute after administering FLUENZA patient loss (1:00pm) consciousness for approximately 3 minutes. She was non responsive for 1 minute and not coherent for another 2 minutes. Her breathing and pulse were stable ambulance was called she was checked by an EMT and cleared to return to work. She has no lasting effects or injuries from the event to date. (3:45pm 9/6/09)
I had existing Gestational Diabetes. It has continued to worsen throughout my pregnancy including after vaccination. I plan to deliver on May 25th.
I started getting a sore throat. My jaw was hurting. I had a headache. I had a red nose and sneezing, and I also had some stiffness. I had ear pain as well. I went to an urgent care. They did a strep test, which was negative. They gave me a steroid and antibiotics shot. They gave me presentation for antibiotics and ear drops.
Received Moderna booster dose in error; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTRATION ERROR (Received Moderna booster dose in error) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In October 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 29-Nov-2021, the patient experienced PRODUCT ADMINISTRATION ERROR (Received Moderna booster dose in error). On 29-Nov-2021, PRODUCT ADMINISTRATION ERROR (Received Moderna booster dose in error) had resolved.            No concomitant medications were reported.  No treatment information was reported.  It was reported that, the patient received the Moderna booster half dose today 29Nov2021 in error. It was unknown if the intramuscular injection was given into the left or right deltoid. The patient was supposed to have received the second full Moderna COVID-19 dose in the series.  Further, he was instructed by the facility to come back tomorrow to receive the Moderna full second dose.      Reporter did not allow further contact
101.9-degree fever, body aches, muscle pain, exhaustion, diarrhea, chills
I had a stroke (cerebral hemorrhage) in the week following my second dose of the Moderna COVID-19 vaccine.
TDAP administered at client's workplace during health dept. onsite clinic. Client reported ED visit on 2-12-11 d/t complaints of shortness of breath, wheezing, & sensation of "throat closing". Drove self to ED where she received oral Prednisone treatment. Also given Prednisone 20 mg tablets #4 to self administer 1 tab po BID x 2 d. States symptoms resolved 2-14-11. No further medical care/eval necessary.
four month old was given Fluarix; This case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 4-month-old female patient who received Flu Seasonal QIV Dresden (Fluarix Quadrivalent 2021-2022 season) (batch number 54C23, expiry date 30th June 2022) for prophylaxis.   Co-suspect products included flu seasonal qiv dresden pre-filled syringe device (Fluarix Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 20th October 2021, the patient received Fluarix Quadrivalent 2021-2022 season and Fluarix Tetra Pre-Filled Syringe Device. On 20th October 2021, unknown after receiving Fluarix Quadrivalent 2021-2022 season and Fluarix Tetra Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The 4 months year old patient received Fluarix, which led to inappropriate age at vaccine administration. The reporter consented to follow up.
I have found accounts of hundreds of others online who are in a similar situation; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of BREAST CANCER METASTATIC ) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BREAST CANCER METASTATIC  (seriousness criterion medically significant). At the time of the report, BREAST CANCER METASTATIC  outcome was unknown.  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant product use was not provided by the reporter. No treatment information was provided.  Company Comment: This case concerns a patient of an unknown age and gender with no reported medical history who experienced the unexpected event Breast cancer metastatic. The event occurred after unspecified dose and dates after mRNA-1273 (Moderna Covid-19 vaccine). The rechallenge was not applicable as event and dosing details were ont disclosed. Causality for the reported event was not provided by the reporter. The benefit-risk relationship of mRNA-1273 (Moderna Covid-19 vaccine) in not affected by this report.  Breast cancer is a medical important event. There is very limited details to clinically assess this event.; Sender's Comments: This case concerns a patient of an unknown age and gender with no reported medical history who experienced the unexpected event Breast cancer metastatic. The event occurred after unspecified dose and dates after mRNA-1273 (Moderna Covid-19 vaccine). The rechallenge was not applicable as event and dosing details were ont disclosed. Causality for the reported event was not provided by the reporter. The benefit-risk relationship of mRNA-1273 (Moderna Covid-19 vaccine) in not affected by this report.  Breast cancer is a medical important event. There is very limited details to clinically assess this event
The patient received the vaccine 09/06/2018. By 09/08/2018 she experienced an itchy rash on both of her arms. She did not call the pharmacy nor her doctor, but treated herself with hydrocortisone cream and diphenhydramine cream. By the reporting date of 09/15/2018 she claims there has been continued improvement, although it is not completely resolved. She has had the FLUZONE High Dose in the past and has never experienced this reaction. She does admit to trying a new recipe with dry yeast for the first time at the same time of her experiencing the allergy, so the cause of the rash is unknown. We are reporting this to VAERS as a precaution.
Nearly immediate nausea, then severe head throbbing and heart racing. Face became very flush and felt hot.
Grade 3 worsening of psoriasis: START DATE 02/21/2021; ONGOING Grade 3 psoriatic arthritis: START DATE 02/27/2021; ONGOING  CLINICAL COURSE: SEVERE FLARE SKIN PSORIASIS, W/ PAIN, PRURITIS AND BLEEDING SECONDARY TO ITCHING.  SEVERE PAIN LEFT SHOULDER (9/10), MILD PAIN RIGHT SHOULDER (1-2/10) W/ COMPROMISE OF ADLs (DRESSING, COMBING HAIR AND TRANSFERRING)  ACTION TAKEN WITH STUDY DRUG (VACCINE): N/A  MANAGEMENT OF BOTH ADVERSE EVENTS: FIRST DOSE OF TREMFYA 100MG SC SCHEDULED FOR 03/25/2021
As RN was rounding patient was c/o ?dizziness and wooziness? and stated she has been feeling this way since vaccinated.  Also says she had a ?buzzing sensation in her head? when she initially sat down in observation area.  Patient reported feeling anxious; initial vital signs at 1334- SpO2-96%, pulse-78, BP 150/86, dizziness 5/10.  Repeat vital signs at 1405- SpO2 96%, Pulse-68, BP 132/80, dizziness 1/10.  Patient offered water and orally hydrated.  After 15 minutes of therapeutic conversation, patient states that she ?feels fine? and dizziness has resolved.  Patient educated on need to seek medical treatment with emergent symptoms after leaving facility- patient verbalized understanding.
35 weeks pregnant, I had no side effects after first vaccine. Less than 24 h after second vaccination, began to experience mild chills and mild lightheadedness. Within 30 minutes of symptoms onset, I had a near syncope with transient hypotension with blood pressure measured 70/40. I required  some assistance from coworkers before my husband was able to pick me up. Once home, symptoms evolved to fever over 100*F, chills, mild nausea, mild headache, and moderate to severe back, hip, and leg pain. Myalgias and joint pain particularly back pain 24-36 h after vaccination was debilitating and prevented sleep overnight. Symptoms as described in the context of acetaminophen use, 500-650 mg every 4-6h.
Felt heavy pressure on my chest, Irregular heart beat, Light Headed, body aches, fever (100-105F), I took Tylenol 500mg every 4 hours for 36 hours and symptoms started to go away.
This spontaneous prospective pregnancy report was received from a nurse referring to a female patient of unknown age. The patient's medical history and concurrent condition were not reported. Concomitant therapy included sterile diluent(manufacturer unknown). In 1989 the patient was vaccinated with a dose of M-M-R II (1 DF, HSA, frequency, route, lot# and expiration date were unknown) for vaccination. In 1993 the patient was vaccinated with the second dose of M-M-R II (1 DF, HSA, frequency, route, lot# and expiration date were unknown) for vaccination. On an unspecified time, after receiving the second dose, the patient became pregnant(Vaccine exposure during pregnancy). The last menstrual period (LMP) and estimated date of delivery (EDD) were not reported. The pregnancy outcome was pending. Currently the patient was not pregnant. It was reported currently the patient was "nonimmune" to rubella. No further doses of M-M-R II had been administered. The outcome of the events was unknown. Causality between M-M-R II and event "Rubella antibody negative" was provided.
No additional AE/PQC.; a patient who received PNEUMOVAX 23 at the age of 11 months and 4 days old.; This spontaneous report has been received from a health care professional (HCP) (conflicting information, also reported as a technician) concerning a 11-months-old patient of unknown gender.  The patient's concurrent conditions, medical history, concomitant therapies and drug/allergy history were not reported.  On 14-FEB-2011, the patient was vaccinated with the first dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23), 0.5 milliliters (ml), once, lot # 0993Z (has been verified to be a valid lot number, expiration date reported as 25-FEB-2012, but upon internal validation established as 05-JAN-2012) for prophylaxis (anatomical location, and route of administration were not reported). No additional adverse event was reported.
She received the vaccines just before 1:30pm. Brought her home and gave her motrin (Just in case she got pain from the vaccines). She woke up at 3:30 pm and had a fever of 103.3, her respirations were 80 and her heart rate was 168. (I am a nurse on a maternity unit, so I am familliar with getting vital signs on children. ) I called the doctor  she said to call her on Thursday morning if she still had a fever and said the rapid respirations and heartbeat were probably from the fever. That day all the way up until currently, she has had worse balance than usual and falls when just standing. She hasn't been eating barely anything but does drink milk and water. She has been sleepier than usual and complains that every little bump hurts. Her fever went up and down from Tuesday to Thursday. On Wednesday it was 102.3 in the morning then only 101.4 after lunch. When I got home from work Wednesday, it was back up to 103. Wednesday night and the next 2 nights she woke up crying a lot during the night (she usually sleeps throught the night) Her fever on Thursday morning was 102.5 but by that afternoon it was only 98.6. That night it was 99.6 but she was still up during the night fussing. She was getting Tylenol and Motrin alternating every three hours from Tuesday through Thursday. Also, frequent wash downs with a cloth or a bath with cloth rubs. Friday morning she no longer had a fever but as I have said, she is still acting like she doesn't feel well as of Saturday night.
Tested positive for COVID/Two weeks after the first shot she had Covid in January; This spontaneous case was reported by a patient family member or friend and describes the occurrence of COVID-19 (Tested positive for COVID/Two weeks after the first shot she had Covid in January) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: INFLUENZA VACCINE (Flu shot was given within one month prior to Moderna vaccine.). Past adverse reactions to the above products included No adverse event with INFLUENZA VACCINE. Concurrent medical conditions included Allergy to antibiotic (Erythromycin) and Drug allergy (Codeine). Concomitant products included ALPRAZOLAM, AMLODIPINE, ATORVASTATIN and ESOMEPRAZOLE for an unknown indication.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, the patient experienced COVID-19 (Tested positive for COVID/Two weeks after the first shot she had Covid in January). At the time of the report, COVID-19 (Tested positive for COVID/Two weeks after the first shot she had Covid in January) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In January 2021, SARS-CoV-2 test: (Positive) Positive. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. The patient received first dose on her deltoid (shoulder). Patient had no medical history relating to mentioned AE and there was no both acute and chronic illnesses at the time of vaccination. Treatment information was not provided.   This case was linked to MOD-2022-658051, MOD-2022-658038 (Patient Link).
This was 2nd shot.  Very soon after first, developed deep internal itch that lasted most of duration between shots.  Knew to either attribute to allergies or the vaccine.  Claritin was not alleviating the way it normally would....  Within 15 minutes of 2nd dose, the now familiar itch intensified.   Other side effect experienced was felt first shot go directly to inflamed spot in problem knee.  No big deal and momentary with first dose.  With second dose, felt immediately go to same spot, but problem knee area swelled and stiffened for several days thereafter.  Both issues seem minor and did not report to doctor.  Reporting here for sake of vaccine side effect data collection.  If itch intensifies I will seek treatment.  Right now it is low grade and can be tuned out.
08feb90 pt vax hepta B.  2hrs later pt became dyspneic and unconscious for apprx. 8hrs.  pt awoke early morning w/ a frontal h/a and nausea.  Pt ex malaise which persisted through the following day. pt recovered.
This spontaneous report was received from a Medical Assistant, referring to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, concurrent conditions, known allergies and concomitant medications was not reported. On 03-FEB-2017, the patient was vaccinated with an expired dose of ZOSTAVAX with lot # L035285 and expiration date on 15-DEC-2016 (anatomical route of vaccination was not provided) for prophylaxis (expired product administered). Furthermore, it was reported that no adverse event occurred and that no product quality issue was involved. Additional information has been requested.
This spontaneous report as received from a nurse (also reported as a medical assistant), refers to an unspecified number of patients of unknown age and gender. No information on patients' concomitant medications, pertinent medical history, drug reactions or allergies was reported. On unknown dates, the patients were vaccinated with improperly stored doses of GARDASIL 9, lot # L026602, expiration date: 19-OCT-2017 (dose, frequency and route of administration were not reported). The administered doses experienced a temperature excursion of 33.4 degrees Fahrenheit for 7 hours. The temperature excursion was detected by a data logger. There were no previous temperature excursions. No adverse effects were reported. This is one of two reports from the same reporter. Additional information has been requested.
Abdominal discomfort; Nausea; Vomiting; This spontaneous case was reported by a nurse and describes the occurrence of ABDOMINAL DISCOMFORT (Abdominal discomfort), NAUSEA (Nausea) and VOMITING (Vomiting) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 15-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, the patient experienced NAUSEA (Nausea) and VOMITING (Vomiting). On an unknown date, the patient experienced ABDOMINAL DISCOMFORT (Abdominal discomfort). At the time of the report, ABDOMINAL DISCOMFORT (Abdominal discomfort) and NAUSEA (Nausea) outcome was unknown and VOMITING (Vomiting) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 30-Jun-2021: follow up received on 30 jun 2021 contain no new information.
Bruising at the injection site for 3+ days, heavy bleeding from injection site, fever, deep chest pain, elevated blood pressure (180/90).
Pt came to ER c/o chest pain, generalized weakness, low fever.  Onset 1 day prior.
allergic reaction on his tongue; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (allergic reaction on his tongue) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. A07A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced HYPERSENSITIVITY (allergic reaction on his tongue). At the time of the report, HYPERSENSITIVITY (allergic reaction on his tongue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications provided. No treatment information provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-076599 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-076599:For second dose
Extreme fatigue, breathlessness, inability to perform normal daily tasks a week after receiving the vaccine, extreme headache (7-9 on pain scale), low oxygen levels (staying in the 93-95 range, occasionally bouncing back up to 97), blue lips, dizziness, facial swelling, confusion/brain fog,  hyper-spasticity, high blood pressure, high pulse, shakiness
after 6-8 hours injection site was very sore and still is at 4PM, at 11:30 AM today I started having chills and by 3:30 PM had a temperature of 100.3.
typical rubeola rash & 3 days fever, onset 10 days p/vax;
Reports nose is dripping; Nauseous; Cold; Increase in urination; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age (reported as 80 [unknown unit]) received her first dose of bnt162b2 (BNT162B2 as reported PFIZER-BIONTECH COVID-19 VACCINE; unknown lot number and expiration date) at unknown vaccination age via an unspecified route of administration on an unspecified date at 0900 at a single dose for covid-19 immunization. Medical history included experiencing anxiety (ongoing) as her husband passed away a month ago (Jan2021). The patient's concomitant medications were not reported. The patient reported her was nose dripping, nauseous, cold and increase in urination on an unspecified date. The patient mentioned that she took ondansetron (ZOFRAN) about an hour ago. The outcome of the events was unknown.   Information on the lot/batch number has been requested.
Red raised warm firm patches at sites of both injections measuring 2 x 3 on RUE and 3 x 5 on LUE; KEFLEX antibiotic given for suspected cellulitis and BENADRYL for reaction.
I am the patient's daughter as well as an RN-BSN. My mother was given the Moderna vaccine on Feb 11, 2021 and on Feb 15, 2021 she had a CVA and MI. She was found on her apt. floor unconscious. She was transferred to the Hospital by ambulance where a CT scan and other tests were done. It was determined she had a stroke and heart attack. My mother was in great health, took no medications, and lived alone in her apt. before this incident. The medical professionals determined she would not recover so she was admitted to hospice and died on Feb. 21, 2021. I believe there is a relationship between the vaccine and the CVA and MI.
headache, chills,  blurred vision,  muffled  hearing, faintedness